Winter opens the discussion by highlighting that millions of Americans with narcolepsy and OSA suffer from undertreated EDS. He sets the stage for understanding the unmet need that solriamfetol addresses.
Pharmacists’ Guide to Solriamfetol for Excessive Daytime Sleepiness in Narcolepsy and OSA
Winter opens the discussion by highlighting that millions of Americans with narcolepsy and OSA suffer from undertreated EDS. He sets the stage for understanding the unmet need that solriamfetol addresses.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
2
FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief
3
What Real-World Data Show About Moving Patients From Humira to Biosimilars
4
Online GLP-1 Sellers Often Skip Clinician Oversight, Secret Shopper Study Finds
5